Nicotinic acetylcholine receptor ligands

Details for Australian Patent Application No. 2004303740 (hide)

Owner AstraZeneca AB

Inventors Jacobs, Robert; Ernst, Glen; Phillips, Eifion

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004303740

PCT Pub. Number WO2005/061495

Priority 60/531,648 22.12.03 US

Filing date 20 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061495 Priority application(s): WO2005/061495

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303741-Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity

2004303738-Nicotinic acetylcholine receptor ligands